Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 167

1.

Effect of levosimendan on survival and adverse events after cardiac surgery: a meta-analysis.

Harrison RW, Hasselblad V, Mehta RH, Levin R, Harrington RA, Alexander JH.

J Cardiothorac Vasc Anesth. 2013 Dec;27(6):1224-32. doi: 10.1053/j.jvca.2013.03.027. Epub 2013 Sep 16. Review.

PMID:
24050857
2.

Levosimendan Reduces Mortality in Adults with Left Ventricular Dysfunction Undergoing Cardiac Surgery: A Systematic Review and Meta-analysis.

Lim JY, Deo SV, Rababa'h A, Altarabsheh SE, Cho YH, Hang D, McGraw M, Avery EG, Markowitz AH, Park SJ.

J Card Surg. 2015 Jul;30(7):547-54. doi: 10.1111/jocs.12562. Epub 2015 May 19.

PMID:
25989324
3.

Levosimendan reduces cardiac troponin release after cardiac surgery: a meta-analysis of randomized controlled studies.

Zangrillo A, Biondi-Zoccai G, Mizzi A, Bruno G, Bignami E, Gerli C, De Santis V, Tritapepe L, Landoni G.

J Cardiothorac Vasc Anesth. 2009 Aug;23(4):474-8. doi: 10.1053/j.jvca.2008.11.013. Epub 2009 Feb 12. Review.

PMID:
19217315
4.

Reducing mortality in cardiac surgery with levosimendan: a meta-analysis of randomized controlled trials.

Landoni G, Mizzi A, Biondi-Zoccai G, Bruno G, Bignami E, Corno L, Zambon M, Gerli C, Zangrillo A.

J Cardiothorac Vasc Anesth. 2010 Feb;24(1):51-7. doi: 10.1053/j.jvca.2009.05.031. Epub 2009 Aug 22. Review.

PMID:
19700350
5.

Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis.

Niu ZZ, Wu SM, Sun WY, Hou WM, Chi YF.

J Cardiovasc Pharmacol. 2014 Feb;63(2):107-12. doi: 10.1097/FJC.0000000000000028. Review.

PMID:
24126568
6.
7.

Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies.

Landoni G, Biondi-Zoccai G, Greco M, Greco T, Bignami E, Morelli A, Guarracino F, Zangrillo A.

Crit Care Med. 2012 Feb;40(2):634-46. doi: 10.1097/CCM.0b013e318232962a. Review.

PMID:
21963578
8.

Prophylactic milrinone for the prevention of low cardiac output syndrome and mortality in children undergoing surgery for congenital heart disease.

Burkhardt BE, Rücker G, Stiller B.

Cochrane Database Syst Rev. 2015 Mar 25;(3):CD009515. doi: 10.1002/14651858.CD009515.pub2. Review.

PMID:
25806562
9.

Early levosimendan administration is associated with decreased mortality after cardiac surgery.

Treskatsch S, Balzer F, Geyer T, Spies CD, Kastrup M, Grubitzsch H, Wernecke KD, Erb JM, Braun JP, Sander M.

J Crit Care. 2015 Aug;30(4):859.e1-6. doi: 10.1016/j.jcrc.2015.03.008. Epub 2015 Mar 13.

PMID:
25837801
10.

Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.

Huang X, Lei S, Zhu MF, Jiang RL, Huang LQ, Xia GL, Zhi YH.

J Zhejiang Univ Sci B. 2013 May;14(5):400-15. doi: 10.1631/jzus.B1200290.

11.

Levosimendan for Prevention of Acute Kidney Injury After Cardiac Surgery: A Meta-analysis of Randomized Controlled Trials.

Zhou C, Gong J, Chen D, Wang W, Liu M, Liu B.

Am J Kidney Dis. 2016 Mar;67(3):408-16. doi: 10.1053/j.ajkd.2015.09.015. Epub 2015 Oct 27.

PMID:
26518388
12.

Levosimendan improves renal outcome in cardiac surgery: a randomized trial.

Baysal A, Yanartas M, Dogukan M, Gundogus N, Kocak T, Koksal C.

J Cardiothorac Vasc Anesth. 2014 Jun;28(3):586-94. doi: 10.1053/j.jvca.2013.09.004. Epub 2014 Jan 18.

PMID:
24447501
13.

Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.

Kolseth SM, Nordhaug DO, Stenseth R, Sellevold O, Kirkeby-Garstad I, Wahba A.

Eur J Cardiothorac Surg. 2009 Dec;36(6):1024-30. doi: 10.1016/j.ejcts.2009.05.001. Epub 2009 Jul 9.

PMID:
19592266
14.

The effects of levosimendan in cardiac surgery patients with poor left ventricular function.

De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ.

Anesth Analg. 2007 Apr;104(4):766-73. Erratum in: Anesth Analg. 2007 Jun;104(6):1544. Dosage error in article text.

PMID:
17377079
15.

Preoperative levosimendan in heart failure patients undergoing noncardiac surgery.

Katsaragakis S, Kapralou A, Markogiannakis H, Kofinas G, Theodoraki EM, Larentzakis A, Menenakos E, Theodorou D.

Neth J Med. 2008 Apr;66(4):154-9.

16.

Meta-analysis of randomized trials of effect of milrinone on mortality in cardiac surgery: an update.

Majure DT, Greco T, Greco M, Ponschab M, Biondi-Zoccai G, Zangrillo A, Landoni G.

J Cardiothorac Vasc Anesth. 2013 Apr;27(2):220-9. doi: 10.1053/j.jvca.2012.08.005. Epub 2012 Oct 10. Review.

PMID:
23063100
17.

Levosimendan infusion in newborns after corrective surgery for congenital heart disease: randomized controlled trial.

Ricci Z, Garisto C, Favia I, Vitale V, Di Chiara L, Cogo PE.

Intensive Care Med. 2012 Jul;38(7):1198-204. doi: 10.1007/s00134-012-2564-6. Epub 2012 Apr 18.

PMID:
22527079
18.

[Levosimendan reduces mortality in cardiac surgery: a systematic review and meta-analysis].

Hernández A, Miranda A, Parada A.

Rev Esp Anestesiol Reanim. 2012 Jan;59(1):6-11. doi: 10.1016/j.redar.2012.02.001. Epub 2012 Mar 14. Review. Spanish.

PMID:
22429630
19.

Levosimendan versus milrinone in neonates and infants after corrective open-heart surgery: a pilot study.

Lechner E, Hofer A, Leitner-Peneder G, Freynschlag R, Mair R, Weinzettel R, Rehak P, Gombotz H.

Pediatr Crit Care Med. 2012 Sep;13(5):542-8. doi: 10.1097/PCC.0b013e3182455571.

PMID:
22622649
20.

Influence of levosimendan on organ dysfunction in patients with severely reduced left ventricular function undergoing cardiac surgery.

Erb J, Beutlhauser T, Feldheiser A, Schuster B, Treskatsch S, Grubitzsch H, Spies C.

J Int Med Res. 2014 Jun;42(3):750-64. doi: 10.1177/0300060513516293. Epub 2014 Apr 29.

PMID:
24781725
Items per page

Supplemental Content

Write to the Help Desk